These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11060287)

  • 1. Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta ) at AP-1 sites.
    Weatherman RV; Scanlan TS
    J Biol Chem; 2001 Feb; 276(6):3827-32. PubMed ID: 11060287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1.
    Walters MR; Dutertre M; Smith CL
    J Biol Chem; 2002 Jan; 277(3):1669-79. PubMed ID: 11700319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
    Weatherman RV; Clegg NJ; Scanlan TS
    Chem Biol; 2001 May; 8(5):427-36. PubMed ID: 11358690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.
    Paech K; Webb P; Kuiper GG; Nilsson S; Gustafsson J; Kushner PJ; Scanlan TS
    Science; 1997 Sep; 277(5331):1508-10. PubMed ID: 9278514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha.
    Maruyama S; Fujimoto N; Asano K; Ito A
    J Steroid Biochem Mol Biol; 2001 Aug; 78(2):177-84. PubMed ID: 11566442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site.
    Weatherman RV; Carroll DC; Scanlan TS
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3129-31. PubMed ID: 11720858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
    Ramsey TL; Risinger KE; Jernigan SC; Mattingly KA; Klinge CM
    Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
    Zhao C; Koide A; Abrams J; Deighton-Collins S; Martinez A; Schwartz JA; Koide S; Skafar DF
    J Biol Chem; 2003 Jul; 278(29):27278-86. PubMed ID: 12736255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha.
    Pace P; Taylor J; Suntharalingam S; Coombes RC; Ali S
    J Biol Chem; 1997 Oct; 272(41):25832-8. PubMed ID: 9325313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.
    Webb P; Nguyen P; Valentine C; Lopez GN; Kwok GR; McInerney E; Katzenellenbogen BS; Enmark E; Gustafsson JA; Nilsson S; Kushner PJ
    Mol Endocrinol; 1999 Oct; 13(10):1672-85. PubMed ID: 10517669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
    Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ
    Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
    Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
    Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
    Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.